Indian frankincense

DB14275ApprovedInvestigationalOrganism Based Therapies

Indian frankincense is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Mechanism: Pharmacologically active on Glycogen synthase kinase-3 beta
Curator reviewed
Also known as: Boswellia Glabra Resin · Boswellia Serrata · Boswellia Serrata Extract · Boswellia Serrata Gum · Boswellia Serrata Gum Extract

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of August 25, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

7Marketed productsAcross 1 country and 5 labellers

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Indian frankincense, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.